CeriBell, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CBLL | NPCE | BWAY | CMP.AX | IRTC | CERS | |
|---|---|---|---|---|---|---|
| Market cap | 1.05B | 457.89M | 451.24M | 45.95M | 4.42B | 487.72M |
| P/E (TTM) | — | — | 48.7 | — | — | — |
| Forward P/E | -16.8 | -61.3 | 22.1 | 7.2 | 112.0 | -483.0 |
| Price/book | 6.6 | 38.4 | 5.7 | 2.0 | 23.7 | 6.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +139.98% | −5.16% | +37.91% | −33.33% | −29.99% | +61.38% |
| Today | −3.11% | +8.37% | +0.54% | 0.00% | +6.04% | +3.21% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All CBLL news ›CeriBell (NASDAQ:CBLL) Sets New 12-Month High – Should You Buy?
Posted by Mitch Edgeman on Oct 31st, 2026 Shares of CeriBell, Inc. (NASDAQ:CBLL – Get Free Report) hit a new 52-week high during trading on Thursday. The company traded as high as $28.19 and last traded at $27.5960, with a volume of 64,614…
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
(Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, ... Ceribell to Participate in the…
Ceribell price target raised to $33 from $29 at TD Cowen
TD Cowen raised the firm’s price target on Ceribell (CBLL) to $33 from $29 and keeps a Buy rating on the shares. The firm notes that its call w... Ceribell price target raised to $33 from $29 at TD Cowen TD Cowen raised the firm’s price…
Analysts’ Top NA Picks: Ceribell, Inc. (CBLL), CoreWeave (CRWV)
There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Ceribell, Inc. (CBLL) and CoreWeave (CRWV) with bullish sentiments. In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on…
Analyzing CeriBell (NASDAQ:CBLL) & DENTSPLY SIRONA (NASDAQ:XRAY)
Posted by Danessa Lincoln on Oct 23rd, 2026 CeriBell (NASDAQ:CBLL – Get Free Report) and DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two…
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
GlobeNewswire 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc (Nasdaq: CBLL) (âCeribellâ), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, t
CeriBell (NASDAQ:CBLL) Stock Price Up 4% – Should You Buy?
Posted by Tristan Rich on Oct 14th, 2026 CeriBell, Inc. (NASDAQ:CBLL – Get Free Report)’s stock price was up 4% during mid-day trading on Monday. The stock traded as high as $24.43 and last traded at $24.5850. 318,852 shares were traded…
Ceribell, Inc. (CBLL) Gets a Buy from Raymond James
Raymond James analyst maintained a Buy rating on Ceribell, Inc. today and set a price target of $29.00. Ceribell, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $28.50. Based on Ceribell, Inc.’s latest…
Ceribell, Inc. (CBLL) Receives a Buy from BTIG
In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Ceribell, Inc., with a price target of $30.00. According to TipRanks, Thibault is an analyst with an average return of -9.1% and a 37.95% success rate.…
Ceribell management to meet with BTIG
Meeting to be held in New York on September 17 hosted by BTIG. Published first on TheFly – the ultimate source for real-time, market-moving bre... Ceribell management to meet with BTIG Meeting to be held in New York on September 17 hosted…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com6
- themarketsdaily.com3
- globenewswire.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.